Nomura Holdings’s SpringWorks Therapeutics SWTX Stock Holding History

Nomura Holdings’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,500	Closed	-$1.04M	–	1924
2025 Q1	$1.04M	Buy	+23,500	New	+$1.08M	﹤0.01%	1263
2024 Q1	–	Sell	-12,690	Closed	-$463K	–	2006
2023 Q4	$463K	Buy	+12,690	New	+$331K	﹤0.01%	1367
2023 Q2	–	Sell	-70,521	Closed	-$1.82M	–	1626
2023 Q1	$1.82M	Sell	70,521 -121,816	-63%	-$3.56M	0.01%	849
2022 Q4	$5M	Buy	+192,337	New	+$4.74M	0.02%	495
2022 Q3	–	Sell	-506,772	Closed	-$13.4M	–	1949
2022 Q2	$13.4M	Buy	+506,772	New	+$18.5M	0.05%	260

Other funds holding SWTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Nomura Holdings's SWTX Position: Q2 2025 in Review

Nomura Holdings sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 23,500 shares — an estimated $1.04M sold.

Nomura Holdings first reported a position in SWTX in Q2 2022 and held it in 5 quarters. The position peaked at $13.4M in Q2 2022. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Nomura Holdings reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Nomura Holdings sold 23,500 SpringWorks Therapeutics shares in Q2 2025, an estimated $1.04M.
Nomura Holdings first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 5 quarters.
Nomura Holdings's SpringWorks Therapeutics position peaked at $13.4M in Q2 2022.
223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.